Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor - PubMed (original) (raw)
. 2008 May 1;27(20):2934-40.
doi: 10.1038/sj.onc.1210957. Epub 2007 Dec 3.
Affiliations
- PMID: 18059341
- DOI: 10.1038/sj.onc.1210957
Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor
C W Menges et al. Oncogene. 2008.
Abstract
The Raf-mitogen-activated protein kinase (MAPK) and phosphatidylinositide 3-kinase (PI3K)-AKT pathways are two downstream effectors of the small GTPase Ras. Although both pathways are positively regulated by Ras, the Raf-MAPK and PI3K-AKT pathways have been shown to control opposing functions within the cell, suggesting a need for cross-talk regulation. The PI3K-AKT pathway can inhibit the Raf-MAPK pathway directly during processes such as muscle differentiation. Here we describe the ability of the Raf-MAPK pathway to negatively regulate the PI3K-AKT pathway during cellular arrest. Constitutive activation of Raf or methyl ethyl ketone 1 (MEK1) leads to inhibition of AKT and cellular arrest. Furthermore, we show that activation of Raf-MEK1 signaling causes negative feedback inhibition of Ras through the ephrin receptor EphA2. EphA2-mediated negative feedback inhibition is required for Raf-induced AKT inhibition and cell cycle arrest, therefore establishing the inhibition of the Ras-PI3K-AKT pathway as a necessary event for the Raf-MEK1-regulated cellular arrest.
Similar articles
- Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L, Myers JN, Sherman SI, Trimarchi F, Clayman GL, El-Naggar AK. Santarpia L, et al. Cancer. 2010 Jun 15;116(12):2974-83. doi: 10.1002/cncr.25061. Cancer. 2010. PMID: 20564403 - Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
Chanprasert S, Geddis AE, Barroga C, Fox NE, Kaushansky K. Chanprasert S, et al. Cell Signal. 2006 Aug;18(8):1212-8. doi: 10.1016/j.cellsig.2005.09.010. Epub 2005 Dec 27. Cell Signal. 2006. PMID: 16380230 - Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA. Chang F, et al. Int J Oncol. 2003 Mar;22(3):469-80. Int J Oncol. 2003. PMID: 12579299 Review. - Raf: a strategic target for therapeutic development against cancer.
Beeram M, Patnaik A, Rowinsky EK. Beeram M, et al. J Clin Oncol. 2005 Sep 20;23(27):6771-90. doi: 10.1200/JCO.2005.08.036. J Clin Oncol. 2005. PMID: 16170185 Review.
Cited by
- Eph receptors and ephrins as targets for cancer therapy.
Xi HQ, Wu XS, Wei B, Chen L. Xi HQ, et al. J Cell Mol Med. 2012 Dec;16(12):2894-909. doi: 10.1111/j.1582-4934.2012.01612.x. J Cell Mol Med. 2012. PMID: 22862837 Free PMC article. Review. - NADPH oxidase 4 signaling in a ventilator-induced lung injury mouse model.
Lee SH, Shin MH, Leem AY, Lee SH, Chung KS, Kim YS, Park MS. Lee SH, et al. Respir Res. 2022 Mar 27;23(1):73. doi: 10.1186/s12931-022-01992-0. Respir Res. 2022. PMID: 35346198 Free PMC article. - Ligands with different dimeric configurations potently activate the EphA2 receptor and reveal its potential for biased signaling.
Gomez-Soler M, Gehring MP, Lechtenberg BC, Zapata-Mercado E, Ruelos A, Matsumoto MW, Hristova K, Pasquale EB. Gomez-Soler M, et al. iScience. 2022 Feb 4;25(3):103870. doi: 10.1016/j.isci.2022.103870. eCollection 2022 Mar 18. iScience. 2022. PMID: 35243233 Free PMC article. - Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R level.
Jørgensen SH, Emdal KB, Pedersen AK, Axelsen LN, Kildegaard HF, Demozay D, Pedersen TÅ, Grønborg M, Slaaby R, Nielsen PK, Olsen JV. Jørgensen SH, et al. Sci Rep. 2024 Nov 21;14(1):28856. doi: 10.1038/s41598-024-77817-5. Sci Rep. 2024. PMID: 39572596 Free PMC article. - Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1.
Lin S, Gordon K, Kaplan N, Getsios S. Lin S, et al. Mol Biol Cell. 2010 Nov 15;21(22):3902-14. doi: 10.1091/mbc.E10-03-0242. Epub 2010 Sep 22. Mol Biol Cell. 2010. PMID: 20861311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous